Related Experiment Video
Updated: Oct 5, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
The double anaerobic threshold in heart failure
Sara Rovai1, Mauro Contini1, Susanna Sciomer2
1Centro Cardiologico Monzino, IRCCS, Milano, Italy.
Double anaerobic threshold (AT) is common in heart failure patients and occurs more frequently with carvedilol than bisoprolol treatment. This finding may be linked to greater sympathetic inhibition and prolonged circulatory time.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Cardiopulmonary exercise testing (CPET) is crucial for heart failure (HF) assessment.
- The anaerobic threshold (AT) is a key CPET parameter, typically determined by multiple methods.
- A lack of concordance between AT methods, termed double AT (DT), occurs in ~10% of healthy individuals.
Purpose of the Study:
- To investigate the frequency of double AT (DT) in heart failure (HF) patients.
- To compare the incidence of DT between bisoprolol and carvedilol treatments.
- To explore the potential link between DT and chemoreflex response in HF.
Main Methods:
- Reanalysis of CPET data from two cross-over studies involving stable HF patients.
- Comparison of CPET parameters during treatment with bisoprolol versus carvedilol.
- Assessment of chemoreflex response differences between the two beta-blockers.
Main Results:
- Double AT (DT) was identified in a high percentage of HF patients (46% with bisoprolol, 66% with carvedilol).
- Carvedilol treatment was associated with a significantly higher incidence of DT compared to bisoprolol (p < 0.01).
- Carvedilol use correlated with reduced peak oxygen uptake and oxygen pulse, suggesting lower peak cardiac output.
Conclusions:
- Double AT (DT) is a frequent finding in heart failure (HF) patients.
- DT occurs more often with carvedilol than bisoprolol, potentially due to greater sympathetic inhibition.
- These results suggest DT may indicate prolonged circulatory time and warrants further research.
Related Concept Videos
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies

